Amed Co., Ltd. (TPEX:7575)

Market Cap	330.00M -63.1%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	30.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	1.50 (13.64%)
Ex-Dividend Date	Oct 1, 2026

Volume	296,484
Open	10.70
Previous Close	11.00
Day's Range	10.50 - 11.45
52-Week Range	8.16 - 32.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Amed Co., Ltd.

Amed Co., Ltd. engages in the research and development, manufacture, and trading of medical equipment in Taiwan. It offers wound care dressing products under the HERADERM brand name; negative pressure wound therapy systems that provides 24-hour oxygen supply to wounds under the Genadyne brand name; and wound treatment systems under the Natrox brand name. The company also provides 7-day long-acting pain reliever injections under the Naldebain brand name. In addition, it offers pressure injectable implantable port kits under the POLYSITE brand; a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2008
• Employees: 165
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7575

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 19, 2026

Data Sources Report a data error